Nanalysis Scientific (TSE:NSCI) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Nanalysis Scientific Corp. and the United States Pharmacopeia have co-published a study demonstrating the effectiveness of benchtop NMR technology for quality control in pharmaceuticals. The study highlights the advantages of this portable NMR solution, including faster measurements and reduced solvent usage, making it an accessible and scalable option for the industry. This advancement positions Nanalysis Scientific to potentially drive growth in pharmaceutical quality assurance globally.
For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.